                               SEQUENCE LISTING

<110> SHERLOCK BIOSCIENCES
 
<120> SYSTEM

<130> 2013065-0367

<140> PCT/US2020/049961
<141> 2020-09-09

<150> 62/897,960
<151> 2019-09-09

<160> 6     

<170> PatentIn version 3.5

<210> 1
<211> 45
<212> PRT
<213> Human immunodeficiency virus

<400> 1
Ala Ile Ser Pro Arg Thr Leu Asn Ala Trp Val Lys Val Val Glu Glu 
1               5                   10                  15      


Lys Ala Asn Pro Asp Cys Lys Thr Ile Leu Lys Ala Leu Gly Pro Ala 
            20                  25                  30          


Ala Thr Leu Glu Glu Met Met Thr Ala Cys Gln Gly Val 
        35                  40                  45  


<210> 2
<211> 57
<212> PRT
<213> Human immunodeficiency virus

<400> 2
Pro Glu Val Ile Pro Met Phe Ser Ala Leu Ser Glu Gly Ala Thr Pro 
1               5                   10                  15      


Gln Asp Leu Asn Thr Met Leu Asn Thr Val Gly Gly His Gln Asn Pro 
            20                  25                  30          


Asp Cys Lys Thr Ile Leu Lys Ala Leu Gly Pro Ala Ala Thr Leu Glu 
        35                  40                  45              


Glu Met Met Thr Ala Cys Gln Gly Val 
    50                  55          


<210> 3
<211> 53
<212> PRT
<213> Human immunodeficiency virus

<400> 3
Ala Ala Met Gln Met Leu Lys Glu Thr Ile Asn Glu Glu Ala Ala Glu 
1               5                   10                  15      


Trp Asp Arg Val His Pro Val His Ala Gly Asn Pro Asp Cys Lys Thr 
            20                  25                  30          


Ile Leu Lys Ala Leu Gly Pro Ala Ala Thr Leu Glu Glu Met Met Thr 
        35                  40                  45              


Ala Cys Gln Gly Val 
    50              


<210> 4
<211> 59
<212> PRT
<213> Human immunodeficiency virus

<400> 4
Gly Gln Met Arg Glu Pro Arg Gly Ser Asp Ile Ala Gly Thr Thr Ser 
1               5                   10                  15      


Thr Leu Gln Glu Gln Ile Gly Trp Met Thr Asn Asn Pro Pro Ile Pro 
            20                  25                  30          


Asn Pro Asp Cys Lys Thr Ile Leu Lys Ala Leu Gly Pro Ala Ala Thr 
        35                  40                  45              


Leu Glu Glu Met Met Thr Ala Cys Gln Gly Val 
    50                  55                  


<210> 5
<211> 51
<212> PRT
<213> Human immunodeficiency virus

<400> 5
Leu Asn Lys Ile Val Arg Met Tyr Ser Pro Thr Ser Ile Leu Asp Ile 
1               5                   10                  15      


Arg Gln Gly Pro Lys Glu Pro Phe Asn Pro Asp Cys Lys Thr Ile Leu 
            20                  25                  30          


Lys Ala Leu Gly Pro Ala Ala Thr Leu Glu Glu Met Met Thr Ala Cys 
        35                  40                  45              


Gln Gly Val 
    50      


<210> 6
<211> 58
<212> PRT
<213> Human immunodeficiency virus

<400> 6
Tyr Val Asp Arg Phe Tyr Lys Thr Leu Arg Ala Glu Gln Ala Ser Gln 
1               5                   10                  15      


Glu Val Lys Asn Trp Met Thr Glu Thr Leu Leu Val Gln Asn Ala Asn 
            20                  25                  30          


Pro Asp Cys Lys Thr Ile Leu Lys Ala Leu Gly Pro Ala Ala Thr Leu 
        35                  40                  45              


Glu Glu Met Met Thr Ala Cys Gln Gly Val 
    50                  55          


